Cancer News and Research

Latest Cancer News and Research

New research at Rhode Island Hospital identifies a treatment for glioblastomas

New research at Rhode Island Hospital has identified a treatment in animal models for glioblastomas - deadly brain tumors which, once diagnosed, offer a poor prognosis and relatively short life expectancy.

20 Jan 2010

Merck’s initiation of EMD 1201081-cetuximab combination Phase 2 trial triggers €3.0M milestone payment

Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon initiation of a Phase 2 trial by Merck KGaA of EMD 1201081, a novel agonist of Toll-like Receptor 9 (TLR9), in combination with cetuximab (Erbitux®) in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

20 Jan 2010

Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced

Sangamo BioSciences, Inc. announced today that preliminary data from the University of Pennsylvania investigator sponsored Phase 1 safety study of Sangamo's zinc finger nuclease (ZFN) based product, SB-728-T, for HIV/AIDS were presented on Friday, January 15, 2010 at the Keystone Symposium Session "HIV Biology and Pathogenesis."

20 Jan 2010

Study shows an intriguing relationship between cancer-related genes and schizophrenia susceptibility

People who inherit a specific form of a gene that puts them on a road to schizophrenia may be protected against some forms of cancer, according to a new study by scientists at The Feinstein Institute for Medical Research.

20 Jan 2010

Researchers propose a new model for breast cell differentiation

A study by researchers at Tufts University School of Medicine, the Sackler School of Graduate Biomedical Sciences at Tufts, and Tufts Medical Center improves our current understanding of the origins of breast cancer. The

19 Jan 2010

Repeated exposure to tobacco smoke makes lung cancer much worse

Repeated exposure to tobacco smoke makes lung cancer much worse, and one reason is that it steps up inflammation in the lung. Scientists at the University of California, San Diego School of Medicine have found that mice with early lung cancer lesions that were repeatedly exposed to tobacco smoke developed larger tumors - and developed tumors more quickly - than unexposed animals.

19 Jan 2010

US Oncology Foundation changes its name to Life Beyond Cancer Foundation

The US Oncology Foundation announced today that it is changing its name to the Life Beyond Cancer Foundation. This new name better captures the essence of hope that the organization aspires to provide to cancer patients and their families.

19 Jan 2010

Social factors still influence access to cancer services

People who develop the most common forms of cancer are still more likely to be diagnosed at a late stage in their disease if they live in a deprived area, new research has found.

19 Jan 2010

AccessDNA and Informed Medical Decisions team up to provide telephone-based genetic counseling services

AccessDNA, Inc., the leading online consumer resource for genetic-related information, services, and support, today announced it has partnered with Informed Medical Decisions, Inc., the only nationwide-network of independent genetic counselors, to provide telephone-based genetic counseling services to AccessDNA’s fast-growing base of online users.

19 Jan 2010

Leafy green vegetables, folate and multivitamins can prevent lung cancer in smokers

Leafy green vegetables, folate, and some multivitamins could serve as protective factors against lung cancer in current and former smokers, according to a study that is a first step in understanding a complex association.

19 Jan 2010

GenVec and Novartis collaborate to develop novel treatments for hearing loss and balance disorders

GenVec and Novartis will collaborate to discover and develop novel treatments for hearing loss and balance disorders. Preclinical results suggest that delivery of the atonal gene using GenVec's innovative adenovector technology may have the potential to restore hearing and balance function.

19 Jan 2010

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Affomix Corporation, a pioneer in high performance antibody technology, announced today a collaboration with City of Hope focused on establishing the clinical utility of “digital proteomics” with next generation sequencers. One of the nation’s top cancer research and treatment centers, City of Hope is a leading provider of molecular diagnostic testing services and an innovator in clinical genetics research.

19 Jan 2010

CBAI collaborates with Center for Stem Cell Awareness to re-sell its stem cell collection and storage services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has contracted with The Center for Stem Cell Awareness to re-sell its stem cell collection and storage services.

19 Jan 2010

PCI Biotech AS completes second dose group in phase I/II study of Amphinex

PCI Biotech AS ( PCIB.OL) reported today that it has completed the successful treatment of the second dose group in the phase I/II study of its proprietary photosensitiser Amphinex® used in combination with the cytotoxic agent bleomycin in cancer patients.

19 Jan 2010

More than half of women with DCIS are spared a mastectomy

Over 60 per cent of women who have a form of breast cancer in the milk ducts (DCIS) are spared a mastectomy, according to latest research published today in the British Journal of Cancer.

19 Jan 2010

Wound Management Technologies engages Miller Tabak to execute its plans for 2010

Wound Management Technologies, Inc., a rapidly growing provider of specialty medical products, announced today that it has engaged National Investment Banking firm Miller Tabak & Co., LLC, a twenty-eight year old institutional trading firm as part of its strategy in accelerating the search for potential partners that will help grow revenues, which are necessary to execute Wound Managements plans for 2010.

19 Jan 2010

NorthBay Healthcare selects PHNS to conduct readiness assessment for ICD-10

PHNS Inc. announced that it has been engaged by NorthBay Healthcare (NorthBay), Fairfield, California, to begin the process of assessing its readiness for its migration from ICD-9 to ICD-10. PHNS was awarded this Phase 1 of a multi-phase project for NorthBay.

19 Jan 2010

Cancer News and Research

Latest Cancer News and Research

New research at Rhode Island Hospital identifies a treatment for glioblastomas

Merck’s initiation of EMD 1201081-cetuximab combination Phase 2 trial triggers €3.0M milestone payment

Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced

Study shows an intriguing relationship between cancer-related genes and schizophrenia susceptibility

Researchers propose a new model for breast cell differentiation

Repeated exposure to tobacco smoke makes lung cancer much worse

US Oncology Foundation changes its name to Life Beyond Cancer Foundation

Social factors still influence access to cancer services

AccessDNA and Informed Medical Decisions team up to provide telephone-based genetic counseling services

Leafy green vegetables, folate and multivitamins can prevent lung cancer in smokers

GenVec and Novartis collaborate to develop novel treatments for hearing loss and balance disorders

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

CBAI collaborates with Center for Stem Cell Awareness to re-sell its stem cell collection and storage services

PCI Biotech AS completes second dose group in phase I/II study of Amphinex

More than half of women with DCIS are spared a mastectomy

Wound Management Technologies engages Miller Tabak to execute its plans for 2010

NorthBay Healthcare selects PHNS to conduct readiness assessment for ICD-10

Findings pave way for designing better antibiotics to target bacterial transcription machinery

Multi-lingual breast health booklet introduced for underserved population of women in GTA

New type of fat-producing cells may speed up treatments for muscular dystrophy and fibrosis

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in